Neuronal Ca 2+ disregulation in diabetes mellitus

Author： Biessels G.J.   ter Laak M.P.   Hamers F.P.T.   Gispen W.H.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.447, Iss.2, 2002-07, pp. : 201-209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of tea catechins on erythrocyte Ca++-pump in type 2 diabetes mellitus

By Rizvi Syed Ibrahim   Zaid Mohd Abu  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 47, Iss. 5, 2009-05 ,pp. : 440-443

Informa Healthcare

Access to resources Recommend Favorite

Linagliptin: In Type 2 Diabetes Mellitus

By Scott Lesley J.  

Drugs, Vol. 71, Iss. 5, 2011-03 ,pp. : 611-624

Adis International

Access to resources Recommend Favorite

The prevention of type 2 diabetes mellitus

By Davies Melanie J.  

Clinical Medicine, Vol. 3, Iss. 5, 2003-09 ,pp. : 470-474

Royal College Of Physicians

Access to resources Recommend Favorite

Lixisenatide for type 2 diabetes mellitus

By Christensen Mikkel   Knop Filip K   Vilsbøøll Tina   Holst Jens J  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 4, 2011-04 ,pp. : 549-557

Informa Healthcare

Access to resources Recommend Favorite

Vitamins and Type 2 Diabetes Mellitus

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 15, Iss. 1, 2015-03 ,pp. : 54-63

Bentham Science Publishers

Access to resources Recommend Favorite